Cat.#: ACPP-1644
| Despition | Vimentin Human Recombinant |
| SIZE | 20 µg |
| Purity | > 95.0% (SDS-PAGE) |
| Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1373 | Human Interleukin 6 (Active) Protein (AC1373) | 10 µg | inquiry |
| ACPP-1605 | Human PNMT Protein (AC1605) | 5 µg | inquiry |
| ACPP-1046 | Recombinant Mouse CD45 Protein (6×His Tag) (AC1046) | 50 µg | inquiry |
| ACPP-1562 | Human TAGLN3 Protein (AC1562) | 5 µg | inquiry |
| ACPP-1629 | Human GDF7 Protein (AC1629) | 2 µg | inquiry |
| ACPP-1606 | Human GAD2 Protein (AC1606) | 50 µg | inquiry |
| ACPP-1010 | Synthetic Nanodisc Human GPR56 Protein (AC1010) | 10 µg | inquiry |
| ACPP-1121 | Recombinant Human GFAP Protein (AC1121) | 25 µl | inquiry |
| ACPP-1325 | Synaptotagmin 1 Blocking Peptide (AC1325) | 250 µg | inquiry |
| ACPP-1263 | MAPK7 Blocking Peptide (AC1263) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.